Antisense epidermal growth factor receptor (EGFR) transfection down-regulates EGFR expression and suppresses the malignant phenotype of human nasopharyngeal carcinoma CNE-2 cell line.
D000818:Animals; D002455:Cell Division; D045744:Cell Line, Tumor; D015536:Down-Regulation; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D005260:Female; D006801:Humans; D051379:Mice; D009303:Nasopharyngeal Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D010641:Phenotype; D016372:RNA, Antisense / Q000627:therapeutic use*; D014162:Transfection
D016372:RNA, Antisense; D066246:ErbB Receptors